secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2024-09-16T23:59:59+00:00
Accession:  0001654954-24-011974
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q3 revenue falls to $2.4M, swings to net loss of $0.3M
----------------------------------------------------------------------

- Q3 revenue $2.4M, down ~$2.2M (48%) from $4.6M in same quarter last year.
- Net loss of $0.3M compared to net income of $0.5M in Q3 last year.
- Nine-month revenue $7.2M (down $6.2M); net loss $0.8M vs net income $1.4M.
- CEO cites challenging investment environment; investing in tech tools to return to profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495424011974/0001654954-24-011974-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495424011974/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-011974

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer